1. Home
  2. TENX vs VINE Comparison

TENX vs VINE Comparison

Compare TENX & VINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • VINE
  • Stock Information
  • Founded
  • TENX 1967
  • VINE 2019
  • Country
  • TENX United States
  • VINE United States
  • Employees
  • TENX N/A
  • VINE N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • VINE Beverages (Production/Distribution)
  • Sector
  • TENX Health Care
  • VINE Consumer Staples
  • Exchange
  • TENX Nasdaq
  • VINE Nasdaq
  • Market Cap
  • TENX 11.4M
  • VINE 12.3M
  • IPO Year
  • TENX N/A
  • VINE 2021
  • Fundamental
  • Price
  • TENX $3.34
  • VINE $0.89
  • Analyst Decision
  • TENX Strong Buy
  • VINE
  • Analyst Count
  • TENX 2
  • VINE 0
  • Target Price
  • TENX $30.00
  • VINE N/A
  • AVG Volume (30 Days)
  • TENX 30.1K
  • VINE 350.6K
  • Earning Date
  • TENX 11-11-2024
  • VINE 11-12-2024
  • Dividend Yield
  • TENX N/A
  • VINE N/A
  • EPS Growth
  • TENX N/A
  • VINE N/A
  • EPS
  • TENX N/A
  • VINE N/A
  • Revenue
  • TENX N/A
  • VINE $1,262,487.00
  • Revenue This Year
  • TENX N/A
  • VINE N/A
  • Revenue Next Year
  • TENX N/A
  • VINE N/A
  • P/E Ratio
  • TENX N/A
  • VINE N/A
  • Revenue Growth
  • TENX N/A
  • VINE N/A
  • 52 Week Low
  • TENX $2.77
  • VINE $0.25
  • 52 Week High
  • TENX $61.20
  • VINE $1.06
  • Technical
  • Relative Strength Index (RSI)
  • TENX 37.74
  • VINE 74.68
  • Support Level
  • TENX $3.28
  • VINE $0.78
  • Resistance Level
  • TENX $3.55
  • VINE $0.94
  • Average True Range (ATR)
  • TENX 0.22
  • VINE 0.10
  • MACD
  • TENX -0.03
  • VINE 0.03
  • Stochastic Oscillator
  • TENX 8.96
  • VINE 88.64

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About VINE Fresh Vine Wine Inc.

Fresh Vine Wine Inc is a producer of low-carb, low-calorie premium wines in the United States. The company's wine collection features a California Cabernet Sauvignon, Pinot Noir, Chardonnay, California Rose wine, and a Limited Reserve Napa Cabernet.

Share on Social Networks: